RARE vs SFB · rev $350.0M vs $6.99B cap
Ultragenyx (RARE) versus Stifel Financial Corporation 5.20% Senior Notes due 2047 (SFB) — a side-by-side from cached financials, not a winner call.
Ultragenyx (RARE) is a biotechnology company listed on US.
Stifel Financial Corporation 5.20% Senior Notes due 2047 (SFB) is a other company listed on NYSE.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
SFB does not have a complete income-statement cache yet.
RARE currently screens at market cap $2.79B. SFB currently screens at market cap $6.99B.
Not investment advice. Open the RARE and SFB stock pages for the full models.
Not investment advice.